26 related articles for article (PubMed ID: 25615400)
1. Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.
Smith DH; Christensen IJ; Jensen NF; Markussen B; Rømer MU; Nygård SB; Müller S; Nielsen HJ; Brünner N; Nielsen KV
PLoS One; 2013; 8(4):e60613. PubMed ID: 23577133
[TBL] [Abstract][Full Text] [Related]
2. Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.
Reijns MAM; Parry DA; Williams TC; Nadeu F; Hindshaw RL; Rios Szwed DO; Nicholson MD; Carroll P; Boyle S; Royo R; Cornish AJ; Xiang H; Ridout K; ; ; Schuh A; Aden K; Palles C; Campo E; Stankovic T; Taylor MS; Jackson AP
Nature; 2022 May; 605(7910):E7. PubMed ID: 35504971
[No Abstract] [Full Text] [Related]
3. Targeting Topoisomerase I in the Era of Precision Medicine.
Thomas A; Pommier Y
Clin Cancer Res; 2019 Nov; 25(22):6581-6589. PubMed ID: 31227499
[TBL] [Abstract][Full Text] [Related]
4. G-quadruplexes on chromosomal DNA negatively regulates topoisomerase 1 activity.
Liang HT; Yan JY; Yao HJ; Zhang XN; Xing ZM; Liu L; Chen YQ; Li GR; Huang J; He YD; Zheng KW
Nucleic Acids Res; 2024 Mar; 52(5):2142-2156. PubMed ID: 38340342
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase 1-dependent R-loop deficiency drives accelerated replication and genomic instability.
Sarni D; Barroso S; Shtrikman A; Irony-Tur Sinai M; Oren YS; Aguilera A; Kerem B
Cell Rep; 2022 Sep; 40(13):111397. PubMed ID: 36170822
[TBL] [Abstract][Full Text] [Related]
6. A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity.
Santos SM; Icyuz M; Pound I; William D; Guo J; McKinney BA; Niederweis M; Rodgers J; Hartman JL
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31575041
[TBL] [Abstract][Full Text] [Related]
7. The Top1 paradox: Friend and foe of the eukaryotic genome.
Kim N; Jinks-Robertson S
DNA Repair (Amst); 2017 Aug; 56():33-41. PubMed ID: 28641942
[TBL] [Abstract][Full Text] [Related]
8. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer.
Caparello C; Meijer LL; Garajova I; Falcone A; Le Large TY; Funel N; Kazemier G; Peters GJ; Vasile E; Giovannetti E
World J Gastroenterol; 2016 Aug; 22(31):6987-7005. PubMed ID: 27610011
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis.
Rømer MU; Nygård SB; Christensen IJ; Nielsen SL; Nielsen KV; Müller S; Smith DH; Vainer B; Nielsen HJ; Brünner N
Mol Oncol; 2013 Feb; 7(1):101-11. PubMed ID: 23110915
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer.
Nygård SB; Christensen IJ; Nielsen SL; Nielsen HJ; Brünner N; Spindler KL
Scand J Gastroenterol; 2014 Jan; 49(1):84-91. PubMed ID: 24256029
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance to topoisomerase I-targeting drugs.
Rasheed ZA; Rubin EH
Oncogene; 2003 Oct; 22(47):7296-304. PubMed ID: 14576839
[TBL] [Abstract][Full Text] [Related]
12. TOP1 gene copy numbers are increased in cancers of the bile duct and pancreas.
Grunnet M; Calatayud D; Schultz NA; Hasselby JP; Mau-Sørensen M; Brünner N; Stenvang J
Scand J Gastroenterol; 2015 Apr; 50(4):485-94. PubMed ID: 25615400
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer.
Kümler I; Balslev E; Poulsen TS; Nielsen SL; Nygård SB; Rømer MU; Christensen IJ; Høgdall E; Moreira J; Nielsen DL; Brünner N; Stenvang J
Int J Cancer; 2015 Oct; 137(8):2000-6. PubMed ID: 25855483
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.
Palshof JA; Høgdall EV; Poulsen TS; Linnemann D; Jensen BV; Pfeiffer P; Tarpgaard LS; Brünner N; Stenvang J; Yilmaz M; Nielsen DL
BMC Cancer; 2017 Jan; 17(1):48. PubMed ID: 28077117
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]